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Reprogramming of somatic cells into induced plurip-
otent stem cells (iPSCs) resets the epigenome to
an embryonic-like state. Vitamin C enhances the re-
programming process, but the underlying mecha-
nisms are unclear. Here we show that the histone
demethylases Jhdm1a/1b are key effectors of
somatic cell reprogramming downstream of vitamin
C. We first observed that vitamin C induces
H3K36me2/3 demethylation in mouse embryonic
fibroblasts in culture and during reprogramming.
We then identified Jhdm1a/1b, two known vitamin-
C-dependent H3K36 demethylases, as potent regu-
lators of reprogramming through gain- and loss-of-
function approaches. Furthermore, we found that
Jhdm1b accelerates cell cycle progression and sup-
presses cell senescence during reprogramming by
repressing the Ink4/Arf locus. Jhdm1b also cooper-
ates with Oct4 to activate the microRNA cluster
302/367, an integral component of the pluripotency
machinery. Our results therefore reveal a role for
H3K36me2/3 in cell fate determination and establish
a link between histone demethylases and vitamin-C-
induced reprogramming.
INTRODUCTION
Somatic cell fate can be reset into a pluripotent-like state by
introducing defined factors known to regulate pluripotency,
including Oct4, Sox2, Klf4, c-Myc, Nanog, and Lin28 (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007;
Yu et al., 2007). This process is normally referred to as nuclear
reprogramming or more simply reprogramming. The resultant
cells are termed iPSCs and are similar to embryonic stem cells
(ESCs) in many aspects, including gene expression profile,
epigenetic marks, and development potential (Kang et al.,
2009; Maherali et al., 2007; Zhao et al., 2009). As such, iPSCs
derived from human subjects have multiple potential applica-
tions ranging from disease modeling for both drug screening
and pathway mapping to cell replacement therapies (ZhangCelet al., 2011; Zhou et al., 2011). Besides, the reprogramming
process may serve as a paradigm for understanding cell fate
determination at the molecular level.
Reprogramming has been so far approached in multiple ways
mechanistically (Plath and Lowry, 2011). For example, Hoched-
linger and colleagues showed that downregulation or upregula-
tion of markers such as Thy1 or SSEA-1 occurs at an early stage,
but activation of pluripotent genes and X chromosome inactiva-
tion are late events (Stadtfeld et al., 2008). By analyzing the
genome-wide DNA binding patterns of the four Yamanaka
factors (Takahashi and Yamanaka, 2006), Plath and colleagues
also delineated the specific contribution of each factor and
uncovered a temporal and separable mode of action (Sridharan
et al., 2009). On the other hand, we and others have shown that
a mesenchymal-to-epithelial transition (MET) initiates and is
necessary for the reprogramming of mouse fibroblasts (Li
et al., 2010; Lin et al., 2009; Samavarchi-Tehrani et al., 2010).
We also showed that microRNA cluster 302/367 promotes re-
programming by accelerating MET, among other events (Liao
et al., 2011; Subramanyam et al., 2011). All together, these
studies have provided a conceptual framework for under-
standing reprogramming at the molecular and cellular level.
The epigenetic state of a cell is determined by the unique
pattern of DNA methylation and histone modifications, and is
responsible for cell- and tissue-specific gene expression pat-
terns. Reprogramming must thus involve mechanisms respon-
sible for changing the epigenetic status of both DNA and
histones genome-wide. Interestingly, despite the fact that the
acquisition of the pluripotent state during reprogramming entails
both DNAmethylations at the promoters of somatic genes (Lister
et al., 2009) and the DNA demethylations at the promoters of
pluripotent genes, the two de novo DNA methyltransferases
Dnmt3a and b are dispensable (Pawlak and Jaenisch, 2011),
suggesting that additional epigenetic enzymes/modifiers play
a relevant role. In this regard, the histone deacetylase inhibitors
valproic acid, suberoylanilide hydroxamic acid, and sodium
butyrate are known to enhance reprogramming (Huangfu et al.,
2008; Liang et al., 2010;Mali et al., 2010), suggesting that histone
deacetylases may represent a roadblock for iPSC generation.
The chromatin remodeling proteins Bgr1 and Baf155, along
with Wdr5, an effector of H3K4 methylation, also have potenti-
ating effect (Ang et al., 2011; Singhal et al., 2010). Moreover,
Meissner and colleagues analyzed the global euchromatin
dynamics in the initial phase of reprogramming and observedl Stem Cell 9, 575–587, December 2, 2011 ª2011 Elsevier Inc. 575
Figure 1. Vitamin C Promotes the Demethylation of H3K36me2/me3 and Accelerates Reprogramming Synergistically with Jhdm1a/1b
(A) Vitamin C (Vc) reduces H3K36me2/3 in mouse fibroblasts in a reversible manner. Ctrl and D indicate control and day, respectively. A representative western
blot is shown.
(B) Vitamin C reduces H3K36me2/3 modification during reprogramming with three factors. Control fibroblasts were infected with GFP retroviruses (this applies
hereafter); the total numberof viruseswaskept constant betweenexperiments.A representativewesternblot is shown. Total histone 3wasusedas loadingcontrol.
(C) DFO and DMOG inhibit SKO reprogramming. The two compounds were added to the media along with vitamin C at indicated concentrations through the
whole experiment. Mean values ± standard deviation (SD) of three independent experiments are shown; this also applies hereafter for any experiment analyzing
reprogramming efficiency. **p < 0.01 with one-way AVONA analysis.
(D) Reprogramming efficiency with SKO + vitamin C is impaired by shRNA (sh) for Jhdm1a/1b. shLuc indicates shRNA against firefly luciferase gene; 1a indicates
Jhdm1a, 1b indicates Jhdm1b. *p < 0.05.
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histone modification level (Koche et al., 2011). Taken together,
these findings show that chromatin remodeling during reprog-
ramming is organized rather than random, and is also suscep-
tible to acceleration.
We previously reported that vitamin C promotes the genera-
tion of mouse and human iPSCs (Esteban et al., 2010). Yet, other
antioxidants, including N-acetylcysteine, vitamin E, and lipoic
acid, have little effect even though they also reduce the level of
free radicals, suggesting that vitamin C may have additional
functions other than that of suppressing free radicals. In fact,
vitamin C critically regulates cellular functions such as collagen
synthesis (Van Robertson and Schwartz, 1953) and hypoxia-
inducible factor stability (Knowles et al., 2003), and also has
been ascribed additional roles in areas ranging from cancer to
the common cold (Traber and Stevens, 2011; Wilson and Loh,
1973). In this report, we demonstrate that vitamin C enhances
iPSC generation at least in part by facilitating the function of
histone demethylases Jhdm1a/1b.
RESULTS
Vitamin C Promotes the Demethylation
of H3K36me2/me3 and Accelerates
Reprogramming Synergistically with Jhdm1a/1b
Vitamin C is a known cofactor for multiple histone demethylases
(Horton et al., 2010), and this led us to hypothesize that mouse
fibroblasts reprogrammed in the presence of vitamin C undergo
changes in the histone methylation status that accelerate the
process. To test this idea, we extracted total histones from
fibroblasts treated with vitamin C at different time points and
analyzed the methylation status by western blotting using anti-
bodies against monomethylated, dimethylated, and trimethy-
lated histone H3 at K4, K9, K27, and K36. Vitamin C consistently
reduced the levels of H3K36me2/3 at days 5 and 7 posttreatment
(Figure 1A and Figure S1A available online), whereas other tested
histone marks did not change noticeably (Figure S1B). Impor-
tantly, when vitamin C was removed from the culture medium,
the level of H3K36me2/3 returned to that of the steady state in
2 days (Figure 1A and Figure S1A), indicating that vitamin C
modulates H3K36 methylation in a reversible way. Vitamin C
also decreased H3K36me2/3 levels, but not other tested histone
marks, during reprogramming mediated by Sox2/Klf4/Oct4
(SKO) (Figure 1B and Figures S1C and S1D). We then treated
fibroblasts transduced with SKO with the iron chelator desfer-
rioxamine (DFO) or the a-ketoglutarate analog dimethyloxalylgly-
cine (DMOG) to test whether the changes in H3K36me2/3 are
driven by vitamin C/iron/a-ketoglutarate-dependent dioxyge-
nases (e.g., the Jumonji family of histone demethylases) (Horton
et al., 2010). DFO and DMOG inhibited SKO reprogramming in(E) shRNA for Jhdm1a/1b reverse the reduction in H3K36me2/3 triggered by SKO
A representative western blot is shown.
(F) Overexpression of Jhdm1a/1b enhance reprogramming efficiency with SKO i
(G) Phase contrast and immunofluorescence microscopy of fibroblasts transduc
45 mm.
(H) Jhdm1a/1b greatly accelerate the kinetics of GFP+ colony appearance in fibrob
See also Figures S1 and S2.
Cela dose-dependent manner, reducing cell proliferation moder-
ately (Figure 1C and Figure S1E). Similar results were obtained
with SKOM (the same factors plus c-Myc) (Figure S1F). These
results suggested that vitamin C influences reprogramming by
removing H3K36me2/3 through vitamin-C-dependent histone
demethylases.
Jhdm1a/1b (sharing 56% homology) belong to the Jumonji
family of proteins and have been shown to demethylate
H3K36me2/3 (He et al., 2008). We analyzed the mRNA level of
Jhdm1a/1b in fibroblasts transduced with SKO or SKOM and
found a moderate increase over the time course of reprogram-
ming with SKOM (Figure S2A left panel). Likewise, the expres-
sion of these two enzymes was 5- to 8-fold greater in ESCs
than in fibroblasts (Figure S2A left panel). Other tested demethy-
lases showed variable increase during reprogramming with
SKO/SKOM and were also expressed at greater levels in ESCs
than in fibroblasts (Figure S2A right panel). To analyze the role
of Jhdm1a/1b in reprogramming, we knocked them down using
shRNA retroviral vectors. The effect of reducing Jhdm1a or 1b
expression independently was moderate, but the combined
knockdown impaired reprogramming efficiency significantly
(Figure 1DandFigure S2B). Importantly, therewas aconcomitant
increase in the levels of H3K36me2/3 (Figure 1E and Figure S2C),
in agreement with vitamin C reducing this histone mark through
Jhdm1a/1b. Knockdown of Jhdm1a/1b also inhibited reprog-
ramming in the absence of vitamin C (Figure S2D). This further
shows that these two enzymes are critical for reprogramming
but also indicates that they can work, albeit likely less efficiently,
without vitamin C.
We then performed gain-of-function studies by overexpress-
ing Jhdm1a/1b and a few additional histone demethylases
together with SKO. Jhdm1a/1b, but not the other enzymes,
enhanced iPSC generation with SKO in the presence (more
significantly) or absence of vitamin C (Figure 1F), and less signif-
icantly with SKOM (Figure S2E). Jhdm1a/1b also accelerated the
reprogramming kinetics in the presence of vitamin C (Figures 1G
and 1H). As expected, DFO and DMOG also counteracted the
enhancing effect of Jhdm1a/1b on reprogramming (Figure S2F).
Our results thus suggest that Jhdm1a/1b play a relevant role in
vitamin-C-enhanced reprogramming.
Jhdm1b Enables Efficient Generation of iPSCs
by Oct4 Alone
We and others have shown that Oct4 is sufficient to reprogram
human and mouse fibroblasts into iPSCs, albeit at extremely
low efficiencies (Chen et al., 2011; Li et al., 2011; Zhu et al.,
2010). We tested the possibility that removal of H3K36me2/3
marks by Jhdm1a/1b would enhance reprogramming efficiency
byOct4 alone.We transducedmouse fibroblasts with KO, SO, or
O, plus either Jhdm1a or 1b, and then treated the reprogrammedand vitamin C. MEF indicates mouse embryonic fibroblasts used as a control.
n the presence or absence of vitamin C.
ed and treated as indicated. 1a indicates Jhdm1a. Scale bar corresponds to
lasts transducedwith SKO. A representative time course experiment is shown.
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Figure 2. Jhdm1b Enables Efficient Generation of iPSCs by Oct4 Alone and This Requires Histone Demethylase Activity
(A) Effect of Jhdm1a/1b on the reprogramming of mouse fibroblasts with fewer factors.
(B) Semiquantitative RT-PCR shows integration of the transgenes into the genome of selected OB clones.
(C) Confocal immunofluorescence microscopy for the indicated markers using a selected OB clone. Nuclei are stained in blue with DAPI. Scale bar corresponds
to 10 mm.
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ming mediated by SO, but only Jhdm1b boosted KO-mediated
reprogramming significantly (Figure 2A). These data indicate
that although Jhdm1a/1b may share some functions, their
mode of action is not identical. In addition, Jhdm1b promoted
Oct4 reprogramming to a level similar to that of KO or SO plus
Jhdm1b, reaching an efficiency of 0.85% (170 clones derived
from 20,000 cells) at day 20 (Figure 2A), while Jhdm1a could
only produce a few clones. This efficiency is greater than OK-
mediated reprogramming under optimized tissue culture condi-
tions (0.02%) (Chen et al., 2010). We referred to clones derived
fromOct4 and Jhdm1b as OB iPSCs. These OB clones had inte-
grated Oct4 and Jhdm1b into the genome, and we verified that
Sox2, Klf4, and c-Myc transgenes were absent (Figure 2B).
They also displayed normal karyotype, silencing of Oct4 and
Jhdm1b transgenes, activation of endogenous pluripotent
markers, and demethylation of Oct4 and Nanog proximal
promoters (Figures S3A–S3E). Immunofluorescence for REX1
and SSEA-1 was likewise comparable to that of mouse ESCs
(Figure 2C), and injection into eight-cell stage wild-type embryos
produced live-born chimeras with germline transmission (Fig-
ure 2D). Therefore, Jhdm1a/1b differ in their ability to enhance
the reprogramming of mouse fibroblasts by two factors or
Oct4 alone.
Jhdm1b Enhances Oct4 Reprogramming through Its
Histone Demethylase Activity
Next, we aimed to understand how Jhdm1b enhances Oct4
reprogramming, as this should explain to a large extent how it
works with two, three, or four factors. Our results above using
DFO and DMOG suggested that Jhdm1a/1b enhance iPSC
generation through their demethylase activity. These two inhibi-
tors impaired as well the reprogramming of fibroblasts trans-
duced withOct4/Jhdm1b and treated with vitamin C (Figure 2E).
Likewise, we observed a significant reduction of H3K36me2/3 in
Oct4/Jhdm1b-transduced fibroblasts treated with vitamin C as
compared with the control-treated cells (Figure 2F lane 2 versus
4 and Figure S4A), and this was reversed by DFO and DMOG
(Figure 2F lanes 2 and 4 versus 5–8, and Figure S4A). Moreover,
we constructed two Jhdm1b mutants lacking either the DNA
binding domain (named CxxC mutant) or the catalytic domain
(Jmjc mutant) respectively (Figure 2G left panel). The zinc finger
CxxC domains of Jhdm1a/1b have been shown recently to
preferentially recognize nonmethylated DNA and then remove
H3K36me2/3 marks (Blackledge et al., 2010). We showed that
both mutants failed to enhance iPSC generation by Oct4 in the
presence or absence of vitamin C (Figure 2G right panel). As ex-
pected, we also showed that both mutants also lacked the ability
to demethylate H3K36me2/3 in the context of reprogramming,(D) Generation of chimeric mice with germline transmission after blastocyst injecti
photographs for the same clones are shown on the left; scale bar corresponds t
(E) DFO and DMOG inhibit reprogramming with Oct4/Jhdm1b/vitamin C.
(F) shRNA for Jhdm1a/1b reverses the reduction in H3K36me2/3 triggered by Oc
(G) Left: scheme depicting the generation of Jhdm1bmutants lacking histone dem
Oct4 reprogramming with vitamin C, unlike wild-type control. Jmjc and CxxC indi
respectively.
(H) Jmjc and CxxC mutants also lack the ability to reduce H3K36me2/3 during re
See also Figures S3 and S4 and Table S1.
Celunlike the wild-type (Figure 2H lane 6 and 8 versus 9–12, Fig-
ure S4B). Hence, we conclude that Jhdm1b promotes Oct4
reprogramming through its histone demethylase activity.
Jhdm1b Promotes Cell Cycle Progression and
Overcomes Cell Senescence during Reprogramming
The significant changes in H3K36me2/3 methylation driven by
Jhdm1b and vitamin C suggest that such genome-wide epige-
netic rearrangements may favor the reprogramming process.
Previous reports have described a role for Jhdm1b in regulating
fibroblast proliferation and senescence through H3K36me2/3
demethylation (He et al., 2008; Tzatsos et al., 2009). Consistent
with this report, we showed that Jhdm1b transduction increased
fibroblast proliferation (Figure 3A). Treatment with vitamin C
enhanced proliferation as well, as reported previously before
(Esteban et al., 2010), and the combination of Jhdm1b and
vitamin C was highly synergistic (Figure 3A). Conversely, the
knockdown of both Jhdm1a/1b significantly inhibited cell growth
even in the presence of vitamin C (Figure 3B, left and right
panels). We also performed DNA microarray analysis of
Jhdm1b-transduced fibroblasts treated with vitamin C and
observed that cell cycle regulators were among the most upre-
gulated genes (Figure 3C). Next, we analyzed the effect of
Jhdm1b/vitamin C on cell proliferation in the context of Oct4 re-
programming. To our surprise, the transduction of Oct4 alone in
fact inhibited the proliferation of fibroblasts (Figures 3D and 3E),
increased the number of G1 cells, and decreased the number of
cells in S and G2/M (Figure 3F), compared with the control. The
proliferation arrest was overcome by Jhdm1b/vitamin C (Figures
3D and 3E), which also reduced the number of cells in G1 phase
and increased the number of S and G2/M cells in the presence or
absence ofOct4 (Figure 3F). We then analyzed the expression of
cell cycle regulators through qPCR and confirmed that Jhdm1b/
vitamin C significantly upregulated key cell cycle regulators in
Oct4-transduced fibroblasts (Figure 3G).
Reprogramming is proliferation dependent, which allows the
progressive acquisition of a pluripotent status (Hanna et al.,
2009), and the Ink4/Arf locus acts as a roadblock in this process
by inducing cell senescence (Li et al., 2009). It is known that
Jhdm1b enhances fibroblast proliferation through repression of
the Ink4/Arf locus by removing H3K36me2/3 marks (He et al.,
2008; Tzatsos et al., 2009). We tested the idea that Jhdm1b
and vitamin C promote Oct4 reprogramming by overcoming
Ink4/Arf-triggered cell senescence. We performed reprogram-
ming of fibroblasts at early or late passage in the presence of
Jhdm1b, vitamin C, or both. Control cells underwent senescence
rapidly and became resistant to reprogramming at passage 6
(P6) (Figures 4A and 4B). Vitamin C or Jhdm1b alone partially
rescued the reprogramming of P6 fibroblasts, and theiron of iPSCs from selected OB clones. Phase contrast and immunofluorescence
o 45 mm.
t4/Jhdm1b/vitamin C.
ethylase or DNA binding activity. Right: bothmutants lack the ability to enhance
cate Jhdm1b mutants lacking the histone demethylase and DNA binding motif,
programming with Oct4 and vitamin C, unlike wild-type control.
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Figure 3. Jhdm1b Promotes Cell Cycle Progression during Reprogramming
(A) Fifty thousand fibroblasts were plated on 6-well plates and transduced/treated as indicated, and the cell number was measured before passaging. A
representative experiment performed in triplicate (each well was counted two times) is shown.
(B) Nine hundred fibroblasts transduced as indicated in a 96-well plate; cell proliferation was measured at different time points using MTT. A representative
experiment out six repeats performed is shown.
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established fibroblasts stably expressing Jhdm1b that could be
reprogrammed at P6 either with vitamin C (more efficiently) or
without it (Figures 4A and 4B). ChIP analysis confirmed that
Jhdm1b binds to different locations in the Ink4/Arf locus in cells
transduced with Oct4/Jhdm1b (Figure 4C) (He et al., 2008; Tzat-
sos et al., 2009). Moreover, Jhdm1b/vitamin C reduced the level
of H3K36me2 at positions 3 (more significantly), 6, and 10 of the
Ink4/Arf locus, while the repressive mark H3K27me3 was
increased (Figure 4D). Consistently, mRNA for p16Ink4a increased
in P6 fibroblasts compared with P2, but was potently reduced in
the presence of Jhdm1b (Figure 4E). As for p15Ink4b, the protein
level was upregulated in late passage (P4 versus P2) and was
further increased by Oct4 alone (Figure 4F), which may help
explain the above-described inhibitory effect of Oct4 on fibro-
blast proliferation (Figures 3D–3F). Next, we induced cell senes-
cence by overexpressing p15 and observed a strong inhibitory
effect on reprogramming that could be partially reversed by
Jhdm1b/vitamin C (Figure 4G). These data suggest that Jhdm1b
promotes Oct4 reprogramming by repressing the Ink4/Arf locus,
which may allow continued proliferation by overcoming cell
senescence.
Jhdm1b Interacts with Oct4 to Activate the Expression
of microRNA Cluster 302/367 during Reprogramming
ESC-specific microRNAs, including the microRNA cluster 302/
367, play an essential role in maintaining the ESC cell cycle
(Wang et al., 2008). Recent reports have shown that components
of this microRNA cluster promote reprogramming mediated by
SKO (Liao et al., 2011; Subramanyam et al., 2011) and can
produce mouse and human iPSCs without additional factors
(Anokye-Danso et al., 2011; Miyoshi et al., 2011). Of note, micro-
RNA cluster 302/367 is a downstream target of Oct4 in mouse
ESCs (Barroso-delJesus et al., 2008). Therefore, we investigated
whether Jhdm1b and Oct4 cooperate to activate the expression
of this cluster, as this may further explain the effects of Jhdm1b
on cell proliferation during Oct4 reprogramming. Interestingly,
Oct4 or Jhdm1b alone failed to induce this microRNA cluster
significantly in transduced fibroblasts, but the combination of
Oct4/Jhdm1b plus vitamin C activated it efficiently (Figure 5A
and Figure S5A). We also observed that transfection of
microRNA-302/367 antagonists (antagomirs) impaired the re-
programming of fibroblasts transduced with SKO and Jhdm1b
(Figure 5B), indicating that activation of these microRNAs is
required for Jhdm1b-enhanced reprogramming.
We investigated the mechanism through which Oct4 and
Jhdm1b regulate the expression of microRNA cluster 302/367
by cloning the corresponding promoter upstream of the firefly
luciferase reporter gene (Figure 5C). We observed that these
two factors cooperate to activate this promoter (Figure 5C), sug-
gesting a physical interaction between them.We also performed(C) Summary of enriched Gene Ontology (GO) terms more potently activated by
(D) Phase contrast photographs of cells transduced/treated as indicated. Scale
(E) Jhdm1b with vitamin C rescues the cell cycle arrest triggered by Oct4 transdu
shown.
(F) Cell cycle analysis with propidium iodide and flow cytometry confirms the res
(G) qPCR analysis of the indicated genes in cells transduced as indicated. The c
See also Table S1.
CelChIP-qPCR on cells infected with Oct4 alone or Oct4 together
with Jhdm1b (wild-type or mutant) in the presence of vitamin
C. Oct4 alone failed to bind to the endogenousmicroRNA cluster
302/367 promoter at its known binding site, but coexpression
with wild-type Jhdm1b (not the mutated version) induced signif-
icant binding (Figure 5D). This suggests that putative histone
modifications catalyzed by Jhdm1b in the nearby chromatin
are required for Oct4 binding and target activation. To search
for putative binding sites of Jhdm1b on the microRNA cluster
302/367 promoter, we designed primer sets that span the entire
promoter region. We performed ChIP-qPCR analysis to show
that Jhdm1b binds to a region near the Oct4 site upon coexpres-
sion with Oct4 (Figure 5E and Figure S5B). Moreover, Oct4 and
Jhdm1b could be coimmunoprecipitated upon cotransfection
in HEK293T cells (Figure S5C). We observed a reduction of
H3K36me2 (more remarkably) and H3K36me3 in the regions
surrounding the Oct4 and Jhdm1b binding sites (Figure 5F).
These data suggest that Jhdm1b and Oct4 interact with each
other to activate microRNA cluster 302/367, which in turn facili-
tates reprogramming.
DISCUSSION
Vitamin C is a natural compound essential to human health
(Traber and Stevens, 2011). It acts at least in part as a cofactor
for enzymatic reactions involving iron and a-ketoglutarate-
dependent dioxygenases. As such, it is necessary for the func-
tion of collagen prolyl hydroxylases, and its deficiency causes
lack of extracellular collagen assembly, leading to scurvy (Peter-
kofsky, 1991). Other susceptible enzymes include Hypoxia-
Inducible Factor prolyl hydroxylases (Knowles et al., 2003) and
many histone demethylases (Horton et al., 2010). We have re-
ported recently that vitamin C accelerates and enhances
somatic cell reprogramming with exogenous factors (Esteban
et al., 2010), a function not ascribable to its antioxidant activity
alone. We then hypothesized in this study that the effect of
vitamin Cmay rely at least in part on its ability to enhance histone
demethylase function, but proof of evidence was missing (Este-
ban et al., 2010). Interestingly, it has also been reported that
vitamin C promotes widespread DNA CpG demethylation in
human ESCs through an unknown mechanism (Chung et al.,
2010), further suggesting a link between vitamin C and epige-
netic remodeling. In this report, we presented evidence that
vitamin C promotes the histone demethylase activities of
Jhdm1a/1b during enhanced reprogramming, and as such, their
knockdown impairs iPSC generation significantly. At this point,
we cannot exclude the possibility that vitamin C and/or
Jhdm1a/1b promote reprogramming through alternative mecha-
nisms. The role of histone demethylases, including members of
the Jumonji family of proteins, in cell fate decisions is well estab-
lished in multiple contexts. For example, LSD1 (which does notJhdm1b/vitamin C; the DNA arrays were performed with cells at passage 1.
bar is 95 mm.
ction into fibroblasts. A representative experiment out six repeats performed is
ults in (E).
ontrol are cells transduced with GFP retroviruses.
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Figure 4. Jhdm1b Overcomes Cell Senescence during Reprogramming by Repressing the Ink4/Arf Locus
(A and B) Jhdm1b/vitamin C overcome the cell senescence roadblock during reprogramming of late passage fibroblasts. Appearance of GFP+ colonies in
fibroblasts transduced/treated as indicated are shown in (A), and the reprogramming efficiency of three independent experiments is measured in (B). Scale bar
indicates 95 mm.
(C) Left: schematic representation of the Ink4/Arf locus. Right: analysis of Jhdm1b binding in this locus using ChIP-qPCR. Mean values of three independent
experiments ± SD are included.
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tiation in human ESCs (Adamo et al., 2011). Likewise, Jmjd1a is
important for Oct4 reactivation in cell-fusion-mediated reprog-
ramming (Ma et al., 2008). However, a role for vitamin C/iron/
a-ketoglutarate histone demethylases in somatic cell reprog-
ramming had not yet been reported. Our results also show
that the overexpression of Jhdm1a/1b potently enhances re-
programming with three (SKO) or fewer factors in the presence
of vitamin C, and Jhdm1b can efficiently produce iPSCs with
Oct4 alone. This is relevant from a practical point of view
because using only one exogenous transcription factor for
inducing reprogramming may allow improved strategies for
understanding the process mechanistically. Moreover, we
have demonstrated that vitamin C induces a global change in
the levels of H3K36me2/3 during reprogramming, suggesting
that the elimination of these histone marks in at least some
loci is necessary for iPSC generation. In this regard, we demon-
strate that removal of H3K36me2/3 in the Ink4/Arf locus and the
promoter of microRNA cluster 302/367 are two relevant mech-
anisms by which Jhdm1b enhances reprogramming (Figure 6).
Activation of the former locus happens naturally during somatic
cell senescence in vitro and is a well-known roadblock of re-
programming (Li et al., 2009). Our results describing repression
of Ink4/Arf by Jhdm1b and prevention of fibroblast senescence
are consistent with published results outside the context of
reprogramming (He et al., 2008; Tzatsos et al., 2009). This
observation also supports our own data showing that vitamin
C enhances iPSC generation at least in part by delaying cell
senescence (Esteban et al., 2010). As for microRNA cluster
302/367, it is known that proper upregulation of its components
is necessary for reprogramming and that they favor the process
through multiple mechanisms, including repression of the Tgfb
signaling pathway and cell cycle modulation (Liao et al., 2011;
Subramanyam et al., 2011). Interestingly, binding and activation
of this microRNA cluster by Oct4 needs the removal of
H3K36me2/3 marks by Jhdm1b, indicating that changes in
this histone modification mark can be associated with both
gene activation and gene repression (Ink4/Arf). It is tempting
to speculate that removal of H3K36me2/3 in other loci influ-
ences as well reprogramming by unrelated mechanisms, but
this needs to be explored further experimentally. It is also inter-
esting to note that the functions of Jhdm1a/1b are similar but
not identical; for example, only Jhdm1b induces Oct4 reprog-
ramming efficiently. A genome-wide mapping of H3K36 marks
along with the binding sites for Jhdm1a/1b should be carried
out with fine resolution during reprogramming with Oct4 and
vitamin C so that their roles in cell fate determination can be
understood in greater detail. Our results also highlight the fact
that although the role of H3K36 modifications in activating or re-
pressing gene expression in ESCs is less clear than that for
other histone modifications (Bernstein et al., 2006; Mikkelsen
et al., 2008), H3K36me2/3 along with their modification(D) ChIP-qPCR analysis of H3K36me2 andH3K27me3methylation in the Ink4/Arf l
with vitamin C. Mean values of three independent experiments ± SD are include
(E and F) Representative qPCR analysis and western blot for p16 mRNA and p1
(G) Jhdm1b/vitamin C partially overcome the reprogramming blockade induced
See also Table S1.
Celenzymes should be investigated further in the context of cell
fate determination.EXPERIMENTAL PROCEDURES
Cell Culture
Mouse embryonic fibroblasts were used throughout the study and were
derived from E13.5 embryos carrying the Oct4-GFP transgene (Esteban
et al., 2010). Fibroblasts and HEK293T cells were maintained in DMEM high
glucose (GIBCO) supplemented with 10% FBS (Hyclone). Mouse iPSCs and
ESCs were maintained on feeder layers (mouse fibroblasts were treated with
mitomycin C) in both mES and KSR media. mES medium consisted of
DMEM high glucose supplemented with 15% FBS (GIBCO), glutamine,
sodium pyruvate, and LIF (Millipore). KSR medium consisted of DMEM high
glucose supplemented with 15% KnockOut Serum Replacement (GIBCO),
glutamine, pyruvate, and LIF. Vitamin C (A4034), DFO, and DMOG were
purchased from Sigma. For reprogramming experiments vitamin C was used
at 50 mg/ml and added from day 2 until the end of each experiment.Western Blotting
Histones were extracted using a reported method (Shechter et al., 2007). Five
micrograms of histone samples were electrophoresized with 15% SDS-PAGE
gels. Detection was performed with ECL+ (Amersham). Antibodies against
histone modifications were purchased as follows: anti-H3K36me1 (Abcam,
ab9048), anti-H3K36me2 (Millipore, 07-274), anti-H3K36me3 (Abcam, ab9050),
anti-H3K27me1 (Millipore, 07-448), anti-H3K27me2 (Abcam, ab24684), anti-
H3K27me3 (Millipore, 07-449), anti-H3K9me1 (Abcam, ab9045), anti-H3K9me2
(Millipore,17-681), anti-H3K9me3 (Abcam, ab8898), anti-H3K4me1 (Abcam,
ab8895), anti-H3K4me2 (Abcam, ab32356), anti-H3K4me3 (Abcam, ab1012),
and anti-H3(Abcam, ab1791). P15 and GAPDH antibodies were purchased
from Cell Signaling Technology. Anti-Oct4 was purchased from Santa Cruz
(SC-8628), and we used Flag antibody (Sigma, F1804) for detection of Jhdm1b
(and also for ChIP).Reprogramming Experiments
pMXs-based retroviral vectors containing the murine cDNAs of Oct4, Sox2,
Klf4, and c-Mycwere purchased from Addgene. Other reprogramming factors
including Jhdm1a and Jhdm1b were cloned to pMXs with PmeI restriction
enzyme. These plasmids were transfected into PlatE cells using the calcium
phosphate transfection method. OG2 cells within the first 2 passages were
split for infection at 3,500 cells per cm2 for iPSC generation. Infections were
carried out as described previously (Esteban et al., 2010). The day that viral
supernatants were removed and the medium added was defined as day 0
postinfection. Picked iPSC colonies were cultured as ESCs. Bisulfite genomic
sequencing and chimeric mouse generation was performed as described
(Esteban et al., 2010).Plasmids
Human Jhdm1a was amplified from H1 cDNA. Murine Jhdm1b, Jmjd1a/1c,
and Jmjd2a/2c/2d were amplified from fibroblast cDNA and cloned into
PmeI site of pMX vector; all plasmids were sequenced and their expression
was confirmed by qPCR. A triplicate flag sequence was tagged at the
C-terminal of Jhdm1b for coimmunoprecipitation and ChIP experiments. pRe-
troSuper vectors containing shRNA sequences for Jhdm1a and Jhdm1b were
designed using the Oligoengine or Sigma website. After infection, cells were
cultured in the presence of puromycin for 4 days. shRNA sequences and other
primers used in this study are included in Table S1 available online.ocus of fibroblasts (control) or those transducedwithOct4/Jhdm1b and treated
d.
5 protein, respectively, in fibroblasts transduced/treated as indicated.
by p15 coexpression in fibroblasts transduced with SKO.
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Figure 5. Jhdm1b Interacts with Oct4 to Activate the Expression of microRNA Cluster 302/367 during Reprogramming
(A) Expression measured by qPCR of the indicated microRNA (miR) components in cells transduced/treated as indicated. A representative experiment is
included.
(B) Transient transfection of the indicated antagomirs impairs reprogramming efficiency of cells transduced with SKO and Jhdm1b plus vitamin C.
(C) Top: scheme of the promoter of microRNA cluster 302/367 cloned upstream of the firefly luciferase gene. Bottom:Oct4 and Jhdm1b cooperate to activate this
reporter in HEK293T cells. Mean values ± SD of three independent experiment are shown.
(D) ChIP-qPCR analysis of Oct4 binding to its cognate site on themicroRNA cluster 302/367 promoter in cells transducedwithOct4/Jhdm1b plus vitamin C.Mean
values of three independent experiments ± SD are included.
(E) Top: scheme of the promoter formicroRNA cluster 302/367 and the different primers used to determine the binding site of Jhdm1b. TSS indicates transcription
start site. Bottom: ChIP-qPCR analysis using those primers. Mean values of three independent experiments ± SD are included.
(F) ChIP-qPCR analysis of H3K36me2/3 and H3K27me3 in the promoter of microRNA cluster 302/367 in fibroblasts reprogrammed with Oct4/Jhdm1b plus
vitamin C compared with the control. Mean values ± SD of three independent experiments are included.
See also Figure S5 and Table S1.
Cell Stem Cell
Vitamin C Enhances Reprogramming through Jhdm1a/1bImmunofluorescence Staining
Immunofluorescence staining was performed as described (Li et al.,
2010). Anti-SSEA-1 was purchased from R&D and anti-Rex1 was pro-
duced by us. A Leica TCS SP2 Spectral confocal microscope was used
for detection.584 Cell Stem Cell 9, 575–587, December 2, 2011 ª2011 Elsevier IncProliferation and Cell Cycle Analysis
Cell proliferation assay was performed with MTT method (Beyotime) following
standard procedure. Cell cycle analysis was performed when cells reached
80% confluence as detected by using the standard propidium iodide method
and flow cytometry analysis..
Figure 6. Schematic Representation of How Jhdm1a/1b and Vitamin
C Enhance Mouse Somatic Cell Reprogramming
Mouse fibroblasts undergo rapid senescence under normal culture conditions
and become resistant to reprogramming. The Yamanaka factors can over-
come the senescence partially. Vitamin C and Jhdm1a/1b can counteract the
senescence very effectively by suppressing p53/p21 (Esteban et al., 2010) and
Ink4/Arf (this study). The activation of microRNA 302/367 by Oct4/Jhdm1b/
vitamin C facilitates efficient reprogramming.
Cell Stem Cell
Vitamin C Enhances Reprogramming through Jhdm1a/1bDNA Microarrays
DNA microarrays were performed using Affymetrix MoGene 1.0 ST chip and
were analyzed with Partek software (Partek).
ChIP
This was done following a previously reported protocol (Nelson et al., 2006).
ChIP-grade anti-Oct4 and control goat IgG were purchased from Santa Cruz
(SC8628X and SC2028), respectively.
Dual Luciferase Reporter Assay
The microRNA cluster 302/367 promoter (1 kb upstream of the transcription
start) was amplified from genomic DNA using primers listed in Table S1, and
was ligated into the pGL3-basic vector. SV40T-Renilla, the expression vectors
forOct4 and Jhdm1b, and the pGL3-promoter were transfected into HEK293T
cells as indicated, and the measurements were performed according to the
instructions of the manufacturer (Promega, Dual-Luciferase Reporter Assay
System).
microRNA Detection and Antagomir Transfection
Total mRNAwas isolated using TRIzol, and 5 mgwere used to synthesize cDNA
using ReverTra Ace (Toyobo) and oligo-dT (Takara). qPCR was performed
using the Premix Ex Taq (Takara) kit and was analyzed with Bio-Rad CFX96
system (Bio-Rad). microRNA assay was detected with stem-loop primers
purchased from Ribobio as described (Liao et al., 2011). U6 small nucleolar
RNA (Guangzhou RiboBio Co., Ltd) was used for the normalization. All items
were measured in triplicate. Antagomirs (Guangzhou RiboBio Co., Ltd) were
transfected 1 and 5 days postinfection using Lipofectamine 2000 (Invitrogen)
following the instructions of the manufacturer.
Immunoprecipitation
HEK293T cells were transfected with the indicated plasmids and lysed 36 hr
after transfection with TNE buffer (150 mM NaCl, 50 mM Tris-Hcl [pH 7.8],
2 mM EDTA, 1% NP-40, and protease inhibitors) at 4C for 1 hr. The lysates
were centrifuged and only the supernatant was collected. FLAG resin (Sigma,
A2220) and anti-Oct4 antibody (Santa Cruz SC-5279) were used for the immu-
noprecipitation, and protein A/G gel (Santa Cruz, SC-2003) was used toCelprecipitate the antigen/antibody complex. FLAG resin and beads were centri-
fuged and washed with TNE buffer 10 times at 4C. For elution we used 50 ml of
Flag peptide or SDS buffer, which were incubated with the beads at room
temperature for 1 hr; the supernatant was collected by centrifugation.
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The accession number for the DNA microarrays gathered in this study is
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